Какова цена за Huaren Pharmaceutical Co., Ltd. (300110)

Цена за Huaren Pharmaceutical Co., Ltd. (300110) Это $0.42025026

Какова рыночная капитализация для Huaren Pharmaceutical Co., Ltd. (300110)

Рыночная капитализация для Huaren Pharmaceutical Co., Ltd. (300110) Это $496.83M

Доходы Huaren Pharmaceutical Co., Ltd. (300110)

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, anti-tumor, and sugar metabolism; and medical instruments, such as disposable incision retractors, disposable cannula puncture devices disposable specimen extractors, abdominal suction tubes, incision retractor protectors, iodine protective caps, slip pads, respiratory oscillation expectoration machines, protective mask cup types, protective and foldable disposable masks, and medical protective masks. In addition, it offers pharmaceutical packaging materials, including rubber stopper, carton, and membrane; rinsing fluid and API series products; and food and beverage, and medical skin care products. The company was founded in 1998 and is based in Qingdao, China.

Год	Выручка	Изменить
Недостаточно данных для указанных дат.

Год

Выручка

Изменить

Недостаточно данных для указанных дат.

Компания	Выручка	Разница в выручке	Страна
STERIS plc STE.US	$6.04B	-	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	-	-	CN
Ypsomed Holding AG YPSN.SW	-	-	CH
Medacta Group S.A. MOVE.SW	-	-	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	-	-	CN

Компания

Выручка

Разница в выручке

Страна